Applying advances to the developing world for TB and HIV control

International Journal of Tuberculosis and Lung Disease

Volumn 4, Issue 2 SUPPL. 1, 2000, Pages

  Harries, A D ^a,b,c  

^a UNIVERSITY OF MALAWI   (Malawi)

^b Malawi Natl Tuberculosis Programme   (Malawi)

^c British High Commission Lilongwe   (Malawi)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AIDS RELATED COMPLEX; BIOTECHNOLOGY; BLOOD TRANSFUSION; CHEMOPROPHYLAXIS; CONFERENCE PAPER; DRUG DEVELOPMENT; HEALTH CARE AVAILABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; PRIORITY JOURNAL; SEXUAL TRANSMISSION; TUBERCULOSIS; TUBERCULOSIS CONTROL; VACCINATION; VERTICAL TRANSMISSION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; ANTITUBERCULAR AGENTS; BCG VACCINE; DEVELOPING COUNTRIES; HIV INFECTIONS; HUMANS; TUBERCULOSIS;

EID: 0034005566     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (35)

1. UNAIDS/WHO. Joint United Nations Programme on HIV/ AIDS (UNAIDS) and the World Health Organization. Report on the global HIV/AIDS epidemic. June 1998.
2. UNAIDS. Joint United Nations Programme on HIV/AIDS. AIDS epidemic update: December 1998.
3. Dolin P J, Raviglione M C, Kochi A. Global tuberculosis incidence and mortality during 1990-2000. Bull World Health Organ 1994; 72: 213-220.
4. Poulsen AG, Aaby P, Larsen O, et al. 9-year HIV-2 associated mortality in an urban community in Bissau, West Africa. Lancet 1997; 349: 911-914.
5. Royce R A, Sena A, Gates W, Cohen M S. Sexual transmission of HIV. N Engl J Med 1997; 336: 1072-1078.
6. Hanenberg R G, Rojanapithayakorn W, Kunasol P, Sokal D C. Impact of Thailand's HIV-control programme as indicated by the decline of sexual transmitted diseases. Lancet 1994; 344: 243-245.
7. Grosskurth H, Mosha F, Todd J, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet 1995; 346: 530-536.
8. Peckham C, Gibb D. Mother-to-child transmission of the human immunodeficiency virus. N Engl J Med 1995; 333: 298-302.
9. Goldenberg R L, Vermund S H, Goepfert A R, Andrews W W. Choriodecidual inflammation: a potentially preventable cause of perinatal HIV-1 transmission? Lancet 1998; 352: 1927-1930.
10. Connor E M, Sperling R G, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994; 331: 1173-1180.
11. Administration of zidovudine during late pregnancy and delivery to prevent perinatal HIV transmission-Thailand, 1996-1998. MMWR Morh Mortal Wkly Rep 1998; 47: 151-154.
12. Savarit D, De Cock K M, Schutz R, Knoate S, Lackritz E, Bondurand A. Risk of HIV infection from transfusion with blood negative for HIV antibody in a west African city. BMJ 1992; 305: 498-501.
13. Wilkinson D, Wilkinson N, Lombard C, et al. On site HIV testing in resource-poor settings: is one rapid test enough? AIDS 1997; 11: 377-381.
14. Montaner J S G, Hogg R, Raboud J, Harrigan R, O'Shaughnessy M O. Antiretroviral treatment in 1998. Lancet 1998; 352: 1919-1922.
15. Palella FJ, Delaney K M, Moorman A C, et al. Declining morbidity and mortality among patients with advanced human im munodeficiency virus infection. N Engl J Med 1998; 338: 853-860.
16. Mocroft A, Vella S, Benfield T L, et al. Changing patterns of mortality across Europe in patients infected with HIV-1. Lancet 1998; 352: 1725-1730.
17. Grant A D, Sidibe K, Domoua K, et al. Spectrum of disease among HIV-infected adults hospitalised in a respiratory medicine unit in Abidjan, Cote d'Ivoire. Int J Tuberc Lung Dis 1998; 2: 926-934.
18. Lucas S B, Hounnou A, Peacock C, et al. The mortality and pathology of HIV infection in a West African city. AIDS 1993; 7: 1569-1579.
19. Morgan D, Mande G H, Malamba S S, et al. HIV-1 disease progression and AIDS-defining disorders in rural Uganda. Lancet 1997; 350: 245-250.
20. Cole S T, Brosch R, Parkhill J, et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 1998; 393: 537-544.
21. Hamburg M A, Frieden T R. Tuberculosis transmission in the 1990s. N Engl J Med 1994; 330: 1750-1751.
22. Menzies D, Fanning A, Yuan L, Fitzgerald M. Tuberculosis among health care workers. N Engl J Med 1995; 332: 92-98.
23. Foulds J, O'Brien R. New tools for the diagnosis of tuberculosis: the perspective of developing countries. Int J Tuberc Lung Dis 1998; 2: 778-783.
24. World Health Organization. Global Tuberculosis Programme. Global Tuberculosis Control. WHO report 1998. WHO/TB/ 98-237. Geneva, Switzerland: World Health Organization, 1998.
25. Pablos-Mendez A, Raviglione M C, Laszlo A, et al. Global surveillance for antituberculosis-drug resistance, 1994-1997. N Engl J Med 1998; 338: 1641-1649.
26. Raviglione M C, Harries A D, Msiska R, Wilkinson D, Nunn P. Tuberculosis and HIV: current status in Africa. AIDS 1997; 11 (Suppl B):S115-S123.
27. Sassan-Morokro M, Wiktor S Z, Abouya L, et al. Significant reduction in mortality attributable to cotrimoxazole prophylaxis among HIV-infected tuberculosis patients in Abidjan, Ivory Coast. 12th World AIDS Conference Geneva. Conference Supplement, page 5-6. Late Breakers Poster Abstracts Ab No. 12461. 1998
28. Wilkinson D, Squire S B, Garner P. Effect of preventive treatment for tuberculosis in adults infected with HIV: systematic review of randomised placebo controlled trials. BMJ 1998; 317: 625-629.
29. Aisu T, Raviglione M, van Praag E, et al. Preventive chemotherapy for HIV-associated tuberculosis in Uganda: an operational assessment at a voluntary counselling and testing centre. AIDS 1995; 9: 267-273.
30. World Health Organization. The World Health Report 1998-life in the 21st century: a vision for all. Geneva, Switzerland: World Health Organization, 1998.
31. Lown B, Bukadi F, Xavier R. Health information in the developing world. Lancet 1998; 352 (Suppl II): SII 34-SII 38.
32. Anonymous. Impact of HIV on delivery of health care in sub Saharan Africa: a tale of secrecy and inertia. Lancet 1995; 345: 1315-1317.
33. Wolffers I, Adjei S, van der Drift R. Health research in the tropics. Lancet 1998; 351: 1652-1654.
34. Horton R. The 12th World AIDS Conference: a cautionary tale. Lancet 1998; 352: 122.
35. World Health Organization. The global tuberculosis research initiative: research to make a difference. WHO/TB/98.248. Geneva, Switzerland: World Health Organization, 1998.